Colofac IBS vs Buscopan: Which Stops Stomach Cramps Better?

When stomach cramps from irritable bowel syndrome (IBS) strike, choosing the right antispasmodic medication can make a significant difference in your comfort and daily life. Colofac IBS (mebeverine) and Buscopan (hyoscine butylbromide) are two popular options, but they work differently and have distinct strengths for managing digestive pain.

Both medications belong to a class called antispasmodics, which work by relaxing the smooth muscle in your digestive tract to reduce cramping and pain. However, Buscopan is specifically indicated for stomach cramps and IBS symptoms, while evidence for mebeverine’s effectiveness in reducing abdominal pain shows more mixed results in clinical studies.

How Do Colofac IBS and Buscopan Work Differently for Stomach Cramps?

Colofac IBS and Buscopan target stomach cramps through different mechanisms, which affects how quickly they work and what type of cramping they address best. Colofac IBS contains mebeverine, which directly acts on smooth muscle cells in the intestinal wall to prevent excessive contractions. Buscopan contains hyoscine butylbromide, which blocks nerve signals that trigger muscle spasms in the digestive tract.

The key difference lies in their selectivity and speed of action. Buscopan works more broadly on the digestive system and can provide faster relief for acute cramping episodes. It blocks anticholinergic receptors, which are the nerve pathways that cause sudden, sharp intestinal spasms. This makes it particularly effective for the type of cramping that comes on suddenly and severely.

Why Pay Full Price?

Search our full medication catalogue and save up to 80% - no insurance needed.

See Prices Now

Mebeverine in Colofac IBS works more selectively on the intestinal smooth muscle itself. It helps normalize bowel muscle contractions rather than completely blocking them, which can be beneficial for ongoing IBS management but may take longer to show effects during acute cramp episodes.

Which Medication Works Faster for Acute Stomach Cramps?

Buscopan typically provides faster relief for acute stomach cramps, often working within 15 to 30 minutes of taking a dose. This rapid action makes it the preferred choice when you need quick relief from sudden, severe cramping episodes that can occur with IBS or other digestive conditions.

The faster onset occurs because hyoscine butylbromide quickly blocks the nerve signals that cause intestinal muscle spasms. When these signals are interrupted, the cramping and pain can subside relatively quickly, providing noticeable relief within the first half hour.

Colofac IBS, while effective for managing IBS symptoms overall, typically takes longer to show its full effects. Most people notice improvement in cramping and other IBS symptoms after taking mebeverine regularly for several days to weeks. This makes it better suited for ongoing management rather than immediate cramp relief.

What Does the Clinical Evidence Say About Their Effectiveness?

Clinical research shows mixed results for both medications, but the evidence favors Buscopan for direct cramp relief. Systematic reviews of mebeverine found that it did not significantly improve global IBS symptoms or abdominal pain compared to placebo, though it was generally well tolerated.

In contrast, a meta-analysis of smooth muscle relaxants, including hyoscine-type medications, found that these antispasmodics improved global symptoms and pain compared to placebo, with no significant difference in adverse events.

More recent reviews of antispasmodics for chronic abdominal pain support the use of both hyoscine and mebeverine, but note that the evidence quality varies. The research suggests that while both medications can help with IBS-related cramping, Buscopan has more consistent evidence for acute pain relief.

Can You Take Both Medications Together Safely?

You should not take Colofac IBS and Buscopan together without consulting your healthcare provider first. While they work through different mechanisms, combining antispasmodic medications can increase the risk of side effects and may not provide additional benefit for cramp relief.

Both medications can cause similar side effects, including constipation, dizziness, and dry mouth. Taking them together could intensify these effects and make them more troublesome. Additionally, the anticholinergic effects of Buscopan combined with mebeverine’s smooth muscle effects could potentially cause excessive slowing of digestive movement.

If one medication is not providing adequate relief, your doctor may suggest switching to the other rather than combining them. They might also recommend adjusting the dosage or timing, or exploring other treatment options that could work alongside your current antispasmodic.

Which Medication Has Fewer Side Effects?

Both Colofac IBS and Buscopan are generally well tolerated, but they have slightly different side effect profiles. Colofac IBS tends to cause fewer anticholinergic side effects like dry mouth and dizziness, while Buscopan may cause more of these effects but is less likely to cause nausea.

Common side effects of Colofac IBS include nausea, loss of appetite, and occasional skin reactions. These effects are typically mild and often improve as your body adjusts to the medication. Because mebeverine works more selectively on intestinal muscle, it generally does not cause the dry mouth, blurred vision, or urinary retention that can occur with anticholinergic medications.

Buscopan’s side effects are related to its anticholinergic action and can include dry mouth, constipation, blurred vision, dizziness, and difficulty urinating. These effects are usually mild but can be more noticeable in older adults or people taking other medications with anticholinergic effects. However, serious side effects are rare with both medications when used as directed.

How Much Do These Medications Cost and Where Can You Save?

The cost difference between Colofac IBS and Buscopan can vary significantly depending on whether you choose brand-name or generic versions, and where you purchase them. Generic mebeverine is typically less expensive than brand-name Colofac IBS, while Buscopan pricing can vary based on the specific formulation and pack size you choose.

Without insurance, a monthly supply of generic mebeverine may cost between $15 and $40, while brand-name Colofac IBS can cost $50 to $80 or more. Buscopan tablets typically range from $10 to $25 for a box of 20.

For patients looking to save on either medication, Universal Drugstore offers competitive cash-pay pricing on both brand-name and generic antispasmodic medications. This can be particularly helpful if your insurance does not cover these medications or if you have a high deductible that makes cash payment more economical.

Who Should Choose Colofac IBS Over Buscopan?

Colofac IBS may be the better choice for people who need ongoing IBS management rather than just acute cramp relief, and for those who want to avoid anticholinergic side effects. It is particularly suitable if you experience IBS symptoms regularly and need a medication you can take daily for prevention.

People with certain medical conditions may also be better candidates for Colofac IBS. If you have glaucoma, enlarged prostate, or other conditions that can be worsened by anticholinergic medications, mebeverine’s more selective action makes it a safer choice. Additionally, if you take other medications that have anticholinergic effects, avoiding Buscopan can help prevent drug interactions.

Colofac IBS is also preferred for people who experience nausea along with their stomach cramps, as mebeverine is less likely to worsen digestive upset compared to anticholinergic medications. If you have tried Buscopan in the past and experienced bothersome side effects like dry mouth or dizziness, Colofac IBS offers an alternative approach to cramp management.

When Is Buscopan the Better Choice for Stomach Cramps?

Buscopan is typically the better choice when you need fast relief from sudden, severe stomach cramps or when your cramping is related to specific triggers like meals or stress. Its rapid action makes it ideal for taking as needed rather than on a daily schedule.

If your stomach cramps are intermittent rather than constant, Buscopan’s as-needed dosing can be more convenient and cost-effective than taking a daily medication. It is also useful for people who want to carry medication for unexpected cramp episodes, such as during travel or stressful periods when IBS symptoms might flare.

Buscopan may also be preferred if you have tried mebeverine without adequate relief, or if your healthcare provider wants to start with a medication that has more direct evidence for acute pain management. Some people find that Buscopan works better for the sharp, colicky type of pain that can occur with IBS, while mebeverine may be less effective for this specific type of cramping.

Can These Medications Help With Other Digestive Issues Besides IBS?

Both medications can help with stomach cramps from various digestive conditions beyond IBS, but Buscopan has broader approved uses. Buscopan is indicated for stomach cramps related to various gastrointestinal conditions, including occasional digestive upset, while Colofac IBS is specifically formulated and marketed for IBS symptom management.

Buscopan can be helpful for cramps associated with gastroenteritis, food poisoning, or other temporary digestive disturbances. Its broad antispasmodic action makes it useful whenever excessive intestinal muscle contractions are causing pain, regardless of the underlying cause.

Mebeverine in Colofac IBS is primarily studied and used for functional digestive disorders like IBS, where the cramping is related to abnormal gut muscle function rather than infection or inflammation. While it may provide some relief for other types of digestive cramping, it is most effective when the underlying problem involves altered gut motility patterns typical of IBS.

References

• Buscopan (hyoscine butylbromide). NHS. Accessed August 17, 2026.
• Mebeverine. NHS. Accessed August 17, 2026.
• Brenner DM, Lacy BE. Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options. Am J Gastroenterol. 2021 Aug 1;116(8):1587-1600. Accessed August 17, 2026.
• Poynard T, Regimbeau C, Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2001 Mar;15(3):355-61. Accessed August 17, 2026.
• Darvish-Damavandi M, Nikfar S, Abdollahi M. A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome. World J Gastroenterol. 2010 Feb 7;16(5):547-53. Accessed August 17, 2026.